DK0717041T3 - Krystallinske paclitaxel-hydrater - Google Patents

Krystallinske paclitaxel-hydrater

Info

Publication number: DK0717041T3
Authority: DK; Denmark
Prior art keywords: hydrates; crystalline paclitaxel; paclitaxel; pseudopolymorph; crystalline
Prior art date: 1994-12-13

Application number

DK95119595T

Other languages

English (en)

Inventor

Scott R Stenberg

Akram Saab

Shreeram Agharkar

Robert K Perrone

Murray A Kaplan

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-13

Filing date

1995-12-12

Publication date

2002-11-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23396320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0717041(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-12-12 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2002-11-25 Application granted granted Critical

2002-11-25 Publication of DK0717041T3 publication Critical patent/DK0717041T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicines Containing Plant Substances (AREA)

DK95119595T 1994-12-13 1995-12-12 Krystallinske paclitaxel-hydrater DK0717041T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US35512594A	1994-12-13	1994-12-13

Publications (1)

Publication Number	Publication Date
DK0717041T3 true DK0717041T3 (da)	2002-11-25

Family

ID=23396320

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95119595T DK0717041T3 (da)	1994-12-13	1995-12-12	Krystallinske paclitaxel-hydrater

Country Status (9)

Country	Link
EP (1)	EP0717041B2 (da)
JP (1)	JPH08208636A (da)
AT (1)	ATE221879T1 (da)
AU (1)	AU699542B2 (da)
CA (1)	CA2163837C (da)
DE (1)	DE69527696T3 (da)
DK (1)	DK0717041T3 (da)
ES (1)	ES2181744T5 (da)
PT (1)	PT717041E (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en)	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
FR2729666A1 (fr) *	1995-01-25	1996-07-26	Rhone Poulenc Rorer Sa	Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
US6495579B1 (en)	1996-12-02	2002-12-17	Angiotech Pharmaceuticals, Inc.	Method for treating multiple sclerosis
US6515016B2 (en)	1996-12-02	2003-02-04	Angiotech Pharmaceuticals, Inc.	Composition and methods of paclitaxel for treating psoriasis
DE69826847T3 (de) †	1997-03-31	2010-05-12	Boston Scientific Ltd., St. Michael	Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
HUP9701945A3 (en) *	1997-11-10	2000-04-28	Hexal Ag	Pharmaceutical composition for injection containing cyclodextrin and taxoids
US6136989A (en) *	1998-12-30	2000-10-24	Phytogen Life Sciences, Incorporated	Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
WO2003079972A2 (en)	2002-02-22	2003-10-02	New River Parmaceuticals Inc.	Active agent delivery systems and methods for protecting and administering active agents
PL203300B1 (pl) *	2000-10-31	2009-09-30	Akad Medyczna	Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
DE10115740A1 (de)	2001-03-26	2002-10-02	Ulrich Speck	Zubereitung für die Restenoseprophylaxe
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
MXPA04005038A (es)	2001-11-30	2004-08-11	Bristol Myers Squibb Co	Solvatos de paclitaxel.
HRP20020614A2 (en) *	2002-07-22	2004-06-30	PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o.	Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
DE10244847A1 (de)	2002-09-20	2004-04-01	Ulrich Prof. Dr. Speck	Medizinische Vorrichtung zur Arzneimittelabgabe
US7919108B2 (en)	2006-03-10	2011-04-05	Cook Incorporated	Taxane coatings for implantable medical devices
US7875284B2 (en)	2006-03-10	2011-01-25	Cook Incorporated	Methods of manufacturing and modifying taxane coatings for implantable medical devices
EP2043704B2 (en) *	2006-06-30	2017-04-19	Cook Medical Technologies LLC	Methods of manufacturing and modifying taxane coatings for implantable medical devices
NZ578341A (en)	2007-01-21	2011-06-30	Hemoteq Ag	Method for producing a coated catheter balloon
US9192697B2 (en)	2007-07-03	2015-11-24	Hemoteq Ag	Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
FR2926551A1 (fr) *	2008-01-17	2009-07-24	Aventis Pharma Sa	Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
EP2944332B1 (en)	2009-07-10	2016-08-17	Boston Scientific Scimed, Inc.	Use of nanocrystals for a drug delivery balloon
WO2011008393A2 (en)	2009-07-17	2011-01-20	Boston Scientific Scimed, Inc.	Nucleation of drug delivery balloons to provide improved crystal size and density
US8889211B2 (en)	2010-09-02	2014-11-18	Boston Scientific Scimed, Inc.	Coating process for drug delivery balloons using heat-induced rewrap memory
US8669360B2 (en)	2011-08-05	2014-03-11	Boston Scientific Scimed, Inc.	Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en)	2011-08-25	2013-02-28	Boston Scientific Scimed, Inc.	Medical device with crystalline drug coating
US9956385B2 (en)	2012-06-28	2018-05-01	The Spectranetics Corporation	Post-processing of a medical device to control morphology and mechanical properties
US10456361B2 (en)	2014-02-14	2019-10-29	Boston Scientific Scimed, Inc.	Rapidly degrading embolic particles with therapeutic agent release

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601675B1 (fr) †	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) †	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5380916A (en) †	1990-11-02	1995-01-10	University Of Florida	Method for the isolation and purification of taxane derivatives
TW467896B (en) †	1993-03-19	2001-12-11	Bristol Myers Squibb Co	Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes

1995
- 1995-11-27 CA CA002163837A patent/CA2163837C/en not_active Expired - Fee Related
- 1995-12-12 DK DK95119595T patent/DK0717041T3/da active
- 1995-12-12 DE DE69527696T patent/DE69527696T3/de not_active Expired - Fee Related
- 1995-12-12 ES ES95119595T patent/ES2181744T5/es not_active Expired - Lifetime
- 1995-12-12 AT AT95119595T patent/ATE221879T1/de not_active IP Right Cessation
- 1995-12-12 EP EP95119595A patent/EP0717041B2/en not_active Expired - Lifetime
- 1995-12-12 AU AU40355/95A patent/AU699542B2/en not_active Ceased
- 1995-12-12 PT PT95119595T patent/PT717041E/pt unknown
- 1995-12-13 JP JP7324202A patent/JPH08208636A/ja active Pending

Also Published As

Publication number	Publication date
DE69527696T2 (de)	2003-04-03
ES2181744T5 (es)	2008-03-01
DE69527696D1 (de)	2002-09-12
AU699542B2 (en)	1998-12-03
ES2181744T3 (es)	2003-03-01
PT717041E (pt)	2002-11-29
JPH08208636A (ja)	1996-08-13
EP0717041B1 (en)	2002-08-07
EP0717041B2 (en)	2007-08-15
DE69527696T3 (de)	2008-04-03
CA2163837C (en)	1999-07-20
ATE221879T1 (de)	2002-08-15
EP0717041A1 (en)	1996-06-19
AU4035595A (en)	1996-06-20
CA2163837A1 (en)	1996-06-14

Publication	Publication Date	Title
DK0717041T3 (da)	2002-11-25	Krystallinske paclitaxel-hydrater
NO943002D0 (no)	1994-08-15	Fosfono-oksymetyletere av taxanderivater
FI952248L (fi)	1995-05-09	Kasvainvastaisia koostumuksia, jotka sisältävät taksaanijohdannaisia
PT960107E (pt)	2003-02-28	Compostos de paclitaxel 6-tio-substituidos
ZA200007222B (en)	2002-03-06	Glycopeptide derivatives and pharmaceutical compositions containing the same.
DK0604910T3 (da)	2000-07-31	Phosphonooxymethylethere af taxanderivater
DK0607389T3 (da)	1998-04-06	Bearbejdelige, cementbaserede sammensætninger
PT1413582E (pt)	2006-07-31	Pirrolobenzodiazepinas dimericas
FI953180A0 (fi)	1995-06-27	Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
CA2152771A1 (en)	1996-01-29	7-o-ethers of taxane derivatives
SE9801494D0 (sv)	1998-04-28	Novel use
DE4493718T1 (de)	1996-08-22	Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
DE60029084D1 (de)	2006-08-10	Neue depsipeptid-verbindung
DK1073447T3 (da)	2007-09-03	N1-modificerede glycopeptider
ATE250340T1 (de)	2003-10-15	7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
GR1002385B (el)	1996-07-03	Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
BR9915898A (pt)	2001-08-21	Compostos, composição farmacêutica, e, utilização de um composto
BR9902081A (pt)	2002-07-23	Combinação de dofetilida e um bloqueador dos canais de cálcio
TWI231815B (en)	2005-05-01	Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents